SODIUM METABISULFITE
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 7681574
- UNII
- 4VON5FNS3C
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Functions of Sodium Metabisulfite
| Bc - Boiler compound |
| Pres - Chemical preservative |
Regulatory Status of Sodium Metabisulfite
| Reg - Food additives for which a petition has been filed and a regulation issued. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| An,cnblk Intrathecal | Injection | |
| An,infiltration | Injection | 0.5% |
| Caudal Block | Injection | 0.18% |
| Dental | Injection | 0.05% |
| Epidural | Injection | 0.18% |
| Im - Iv - Sc | Injection | 0.15% |
| Im - Iv - Sc | Solution, Injection | |
| Infiltration | Injection | |
| Inhalation | Solution | 1% |
| Intra-Articular | Injection | 0.2% |
| Intrabursal | Injection | 0.2% |
| Intracardiac | Injection | 0.09% |
| Intracardiac | Solution, Injection | |
| Intramuscular | Injection | 27.5% |
| Intramuscular | Solution, Injection | 0.1% |
| Intraperitoneal | Injection | 0.33% |
| Intravenous | Emulsion, Injection | 0.03% |
| Intravenous | Injection | 0.32% |
| Intravenous | Solution, Injection | 0.1% |
| Iontophoresis | Patch, Controlled Release | 0.5MG |
| Iontophoresis | Solution | 0.05% |
| Iv(infusion) | Injection | 1.1% |
| Iv(infusion) | Solution, Injection | 0.22% |
| Nerve Block | Injection | 0.5% |
| Nerve Block | Solution, Injection | 0.05% |
| Ophthalmic | Solution | 0.25% |
| Ophthalmic | Solution, Drops | 0.1% |
| Ophthalmic | Suspension, Drops | 0.1% |
| Oral | Capsule | 0.36MG |
| Oral | Concentrate | 0.2% |
| Oral | Liquid | 0.02% |
| Oral | Suspension | 5MG |
| Oral | Syrup | 0.02% |
| Oral | Tablet | 8MG |
| Peridural | Injection | |
| Rectal | Tablet | 2MG |
| Subcutaneous | Injection | 0.3% |
| Subcutaneous | Solution, Injection | 0.1% |
| Sublingual | Tablet | 2MG |
| Submucosal | Solution, Injection | 5% |
| Topical | Cream, Augmented | 0.2% |
| Topical | Emulsion, Cream | |
| Topical | Lotion | 0.2% |
| Topical | Patch | 0.004MG |
| Topical | Patch, Controlled Release | 0.5MG |
| Topical | Powder, For Solution | |
| Topical | Suspension | 0.32%W/V |
| Vaginal | Sponge | 1.5MG |